Spatiotemporally controllable diphtherin transgene system and neoantigen immunotherapy
Journal of Controlled Release · 2023
DOI: 10.1016/j.jconrel.2022.08.059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2023. Verfasst von Muye He und 15 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Functional Materials Chemistry, East China University of Science and Technology, Shanghai 200237, China; Shanghai Key Labo…. Hauptthemen laut MEDLINE: Neoplasms, Cancer Vaccines. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Individualized immunotherapy has attracted great attention due to its high specificity, effectiveness, and safety. We used an exogenous antigen to label tumor cells with MHC I molecules, which allowed neoantigen-specific T cells to recognize and kill tumor cells. A neoantigen vaccine alone cannot achieve complete tumor clearance due to a tumor immunosuppressive microenvironment. The LightOn system was developed to effectively eliminate tumor cells through the spatiotemporally controllable expression of diphtheria toxin A fragment, leading to antigen release in the tumor region. These antigens stimulated and enhanced immunological function and thus, recruited neoantigen-specific T cells to infiltrate tumor tissue. Using the nanoparticle delivery system, neoantigens produced higher delivery efficiency to lymph nodes and improved tumor targeting ability for tumor cell labelling. Good tumor inhibition and prolonged survival were achieved, while eliciting a strong immune response. The combination of a spatiotemporally controllable transgene system with tumor neoantigen labeling has great potential for tumor immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Functional Materials Chemistry, East China University of Science and Technology, Shanghai 200237, China; Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University o…
- Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China.
- Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China; Interventional Cancer Institute of Chinese Integrative Medicine, Putuo Hospital, S…
- Shanghai Key Laboratory of Functional Materials Chemistry, East China University of Science and Technology, Shanghai 200237, China.
- Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China; Optogenetics and Synthetic Biology Interdisciplinary Research Center, State Key La…
Zitieren
APA
He, M., Sun, Y., Cheng, Y., Wang, J., Zhang, M., Sun, R., Hou, X., Xu, J., He, H., Wang, H., Yuan, Z., Lan, M., Zhao, Y., Yang, Y., Chen, X., & Gao, F. (2023). Spatiotemporally controllable diphtherin transgene system and neoantigen immunotherapy. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2022.08.059
Vancouver
He M, Sun Y, Cheng Y, Wang J, Zhang M, Sun R, et al. Spatiotemporally controllable diphtherin transgene system and neoantigen immunotherapy. Journal of Controlled Release. 2023. doi:10.1016/j.jconrel.2022.08.059
BibTeX
@article{He2023,
author = {He, Muye and Sun, Yuji and Cheng, Yi and Wang, Jie and Zhang, Miao and Sun, Rui and Hou, Xinyu and Xu, Jiajun and He, Hai and Wang, Hongtao and Yuan, Zeting and Lan, Minbo and Zhao, Yuzheng and Yang, Yi and Chen, Xianjun and Gao, Feng},
title = {Spatiotemporally controllable diphtherin transgene system and neoantigen immunotherapy},
journal = {Journal of Controlled Release},
year = {2023},
doi = {10.1016/j.jconrel.2022.08.059}
}
EUVIMED